Institutional Ownership
Edgewise Therapeutics Inc
CUSIP 28036F105COMEWTXQ1 2026
13D / 13G Filings
59
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
27.8%
Max % of class reported
Institutional Holders
208
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
59 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Paradigm Biocapital Advisors LP | 13G/A | 6.2% | 9.23B | SEC |
| 2 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 4.7% | 4.98M | SEC |
| 3 | Nov 14, 2025 | Ra Capital Management, L.P. | 13G/A | 9.9% | 10.43M | SEC |
| 4 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.2% | 5.50M | SEC |
| 5 | Aug 14, 2025 | Baker Bros. Advisors LP | 13G/A | 6.9% | 7.31M | SEC |
| 6 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | 4.4% | 4.64M | SEC |
| 7 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 5.5% | 5.82M | SEC |
| 8 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 6.1% | 6.40M | SEC |
| 9 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.6% | 5.28M | SEC |
| 10 | May 12, 2025 | Orbimed Advisors LLC | 13D/A | 14.5% | — | SEC |
49 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Edgewise Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 15.52M | $488.83M |
| 2 | Ra Capital Management, L.P. | 10.43M | $328.50M |
| 3 | Paradigm Biocapital Advisors LP | 7.37M | $232.00M |
| 4 | Baker Bros. Advisors LP | 6.58M | $207.14M |
| 5 | Blackrock, Inc. | 6.47M | $203.90M |
| 6 | Janus Henderson Group PLC | 5.92M | $186.29M |
| 7 | Novo Holdings A/S | 5.35M | $168.53M |
| 8 | Driehaus Capital Management LLC | 4.48M | $141.06M |
| 9 | Siren, L.L.C. | 4.43M | $139.55M |
| 10 | Perceptive Advisors LLC | 4.42M | $139.36M |